Walleye Capital LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 168 filers reported holding VIKING THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,527,809
+54.1%
94,251
+58.2%
0.01%
-60.0%
Q1 2023$991,741
-50.5%
59,564
-72.1%
0.02%
-59.5%
Q4 2022$2,005,123
-32.9%
213,311
-80.6%
0.04%
-35.1%
Q3 2022$2,987,000
+249.4%
1,098,330
+271.1%
0.06%
+137.5%
Q2 2022$855,000
+270.1%
296,000
+284.3%
0.02%
+300.0%
Q1 2022$231,000
+26.9%
77,018
+238.7%
0.01%
-50.0%
Q4 2019$182,000
-40.5%
22,736
+29.4%
0.01%
-91.6%
Q3 2018$306,00017,5740.14%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders